Sun Pharma Gets FDA Nod for Alzheimer’s Generic

Sun Pharmaceuticals has received approval from the US Food and Drug Administration to launch a generic version of Forest Laboratories’ Namenda tablets used to treat Alzheimer’s disease.
The Economic Times